{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:13:24Z","timestamp":1753892004035,"version":"3.41.2"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The primary treatment for eligible patients with hepatocellular carcinoma (HCC) is curative liver resection, offering a 5-year overall survival (OS) of 60%-80%. Despite this, the recurrence rate within five years post-resection remains notably high, ranging from 40% to 50%. Instances of recurrence in the maxillary sinus following liver resection are exceedingly uncommon. This report details a unique case of solitary maxillary sinus recurrence after the curative resection of HCC, which underwent maxillary tumor resection, along with a comprehensive review of pertinent literature. No similar cases have been documented previously.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>In 2014, an 85-year-old male patient was diagnosed with HCC and subsequently underwent left hepatectomy. Following the resection, the patient underwent a 9-year follow-up period without any evidence of intra or extrahepatic recurrence. In 2023, a computed tomography (CT) scan revealed a 1.4\u00a0cm by 1.1\u00a0cm mass in the maxillary sinus, without discernible invasion of the alveolar sinus, nasal cavity, orbital cavity, or infratemporal space. We proceeded with the resection of the maxillary sinus mass. Patho-histochemical analysis indicated that the tumor cells in the maxillary sinus were metastatic HCC cells. As of now, the patient remains in good condition with no signs of tumor recurrence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>For patients presenting with solitary maxillary sinus metastasis, optimal liver function, and a favorable performance score, tumor resection may be the preferred treatment option. However, given the rarity of such cases, larger prospective trials are essential to determine an optimal treatment strategy that offers therapeutic benefits.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1279126","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T04:40:43Z","timestamp":1706503243000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report and literature analysis: solitary HCC- recurrence in the right maxillary sinus after curative resection"],"prefix":"10.3389","volume":"14","author":[{"given":"Tinotenda Blessing","family":"Madzikatire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfeng","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/hepr.13612","article-title":"Report of the 21st nationwide follow-up survey of primary liver cancer in Japan (2010-2011)","volume":"51","author":"Kudo","year":"2021","journal-title":"Hepatol Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s12328-021-01394-7","article-title":"Intrahepatic recurrence of hepatocellular carcinoma after resection: an update","volume":"14","author":"Tampaki","year":"2021","journal-title":"Clin J Gastroenterol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2023.1115181","article-title":"Case report and literature review: Isolated HCC- recurrence in gallbladder after curative resection","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1054\/ijom.2002.0242","article-title":"Metastatic hepatocellular carcinoma of the maxillary sinus: a rare autopsy case without lung metastasis and a review","volume":"32","author":"Okada","year":"2003","journal-title":"Int J Oral Maxillofac Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2298\/VSP1104359K","article-title":"Metastasis of hepatocellular carcinoma presented as a tumor of the maxillary sinus and retrobulbar tumor","volume":"68","author":"Kolarevic","year":"2011","journal-title":"Vojnosanit Pregl"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-59980070032-5","article-title":"Hepatocarcinoma: metastasis to the nose and paranasal sinuses","volume":"122","author":"Izquierdo","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2006.08.012","article-title":"Sinonasal metastatic hepatocellular carcinoma","volume":"28","author":"Huang","year":"2007","journal-title":"Am J Otolaryngol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-005-1000-8","article-title":"A case of metastatic hepatocellular carcinoma in the nasal cavity","volume":"263","author":"Matsuda","year":"2006","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B10","article-title":"Gingival lesions and nasal obstruction in an immunosuppressed patient post-liver transplantation","volume":"65","author":"English","year":"2000","journal-title":"Cutis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/BF02774822","article-title":"Hepatocellular carcinoma metastatic to the oral cavity including the maxilla and the mandible: report of two cases and review of the literature","volume":"20","author":"Horie","year":"1985","journal-title":"Gastroenterol Jpn"},{"key":"B13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.surg.2006.06.033","article-title":"Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection","volume":"141","author":"Yang","year":"2007","journal-title":"Surgery"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1993.tb00128.x","article-title":"Metastases to the oral mucosa: analysis of 157 cases","volume":"22","author":"Hirshberg","year":"1993","journal-title":"J Oral Pathol Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13000-015-0313-1","article-title":"Extrahepatic metastases as initial manifestations of hepatocellular carcinoma: an Egyptian experience","volume":"10","author":"Helal Tel","year":"2015","journal-title":"Diagn Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-021-03151-3","article-title":"Hepatocellular carcinoma: metastatic pathways and extra-hepatic findings","volume":"46","author":"Arora","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2003.09.018","article-title":"Oral metastasis of a hepatocellular carcinoma","volume":"97","author":"Pires","year":"2004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2019.11.20","article-title":"Diagnostic value of glypican-3, arginase-1 and hepatocyte paraffin antigen -1 in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma","volume":"9","author":"Wang","year":"2020","journal-title":"Transl Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.14701\/kjhbps.2012.16.3.93","article-title":"Extrahepatic recurrence of hepatocellular carcinoma after curative hepatic resection","volume":"16","author":"Byeon","year":"2012","journal-title":"Korean J Hepatobil Pancreat Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"31024634","DOI":"10.7573\/dic.212577","article-title":"Second-line treatment options in hepatocellular carcinoma","author":"Marino","year":"2019","journal-title":"Drugs Context"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the asia-pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.37808","article-title":"Sorafenib in the treatment of advanced hepatocellular carcinoma","volume":"14","author":"Ben Mousa","year":"2008","journal-title":"Saudi J Gastroenterol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1915745","article-title":"\u201cAtezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"\u201d New Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i21.5754","article-title":"Treatment strategies for hepatocellular carcinoma with extrahepatic metastasis","volume":"9","author":"Long","year":"2021","journal-title":"World J Clin cases"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.4_suppl.475","article-title":"Impact of antitumor activity on survival outcomes, and nonconventional benefit, with nivolumab (nivo) in patients with advanced hepatocellular carcinoma (ahcc): subanalyses of checkmate-040","volume":"36","author":"El-Khoueiry","year":"2018","journal-title":"J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30351-6","article-title":"Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (keynote-224): a non-randomised, open-label phase 2 trial","volume":"19","author":"Zhu","year":"2018","journal-title":"Lancet Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2739\/kurumemedj.50.41","article-title":"Prognostic efficacy of treatment for extrahepatic metastasis after surgical treatment of hepatocellular carcinoma","volume":"50","author":"Imamura","year":"2003","journal-title":"Kurume Med J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25960","article-title":"Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors","volume":"117","author":"Uchino","year":"2011","journal-title":"Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1998.00846.x","article-title":"Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma","volume":"85","author":"Lam","year":"1998","journal-title":"Br J Surg"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn.2018.08.01","article-title":"Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus","volume":"7","author":"Wen","year":"2018","journal-title":"Hepatobil Surg Nutr"},{"key":"B34","article-title":"Adrenal metastasis from hepatocellular carcinoma (HCC): report of 3 cases","volume":"46","author":"Taniai","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-4001(98)80120-7","article-title":"[Adrenal metastases of hepatocellular carcinoma. Therapeutic options]","volume":"123","author":"Rousselet","year":"1998","journal-title":"Chirurgie"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1279126\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T04:40:45Z","timestamp":1706503245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1279126\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":35,"alternative-id":["10.3389\/fonc.2024.1279126"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1279126","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2024,1,29]]},"article-number":"1279126"}}